These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 17184862)

  • 21. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening].
    Schirlin D; Galvan M; Le Fur G
    Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of drug intermediates by using direct organocatalytic multi-component reactions.
    Ramachary DB; Kishor M; Reddy GB
    Org Biomol Chem; 2006 May; 4(9):1641-6. PubMed ID: 16633553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early chemical development at Legacy Wyeth Research.
    O'Brien MK; Kolb M; Connolly TJ; McWilliams JC; Sutherland K
    Drug Discov Today; 2011 Jan; 16(1-2):81-8. PubMed ID: 21111844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Process technologies for purity enhancement of large discovery libraries.
    Pottorf RS; Player MR
    Curr Opin Drug Discov Devel; 2004 Nov; 7(6):777-83. PubMed ID: 15595438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applications of biotransformations and biocatalysis to complexity generation in organic synthesis.
    Hudlicky T; Reed JW
    Chem Soc Rev; 2009 Nov; 38(11):3117-32. PubMed ID: 19847346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enabling continuous-flow chemistry in microstructured devices for pharmaceutical and fine-chemical production.
    Kockmann N; Gottsponer M; Zimmermann B; Roberge DM
    Chemistry; 2008; 14(25):7470-7. PubMed ID: 18613163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Industrial biocatalysis.
    Zaks A
    Curr Opin Chem Biol; 2001 Apr; 5(2):130-6. PubMed ID: 11282338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients.
    LaPorte TL; Wang C
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):738-45. PubMed ID: 17987525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical synthesis in microreactors.
    Watts P; Haswell SJ
    Methods Mol Biol; 2010; 583():109-20. PubMed ID: 19763461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging technologies supporting chemical process R&D and their increasing impact on productivity in the pharmaceutical industry.
    Rubin AE; Tummala S; Both DA; Wang C; Delaney EJ
    Chem Rev; 2006 Jul; 106(7):2794-810. PubMed ID: 16836299
    [No Abstract]   [Full Text] [Related]  

  • 31. A 'Fine' chemical industry for life science products: green solutions to chemical challenges.
    Bruggink A; Straathof AJ; van der Wielen LA
    Adv Biochem Eng Biotechnol; 2003; 80():69-113. PubMed ID: 12747542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An integrated approach to developing chemoenzymatic processes at the industrial scale.
    Tao J; Zhao L
    Ernst Schering Found Symp Proc; 2006; (3):117-31. PubMed ID: 17695713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly engineered biocatalysts for efficient small molecule pharmaceutical synthesis.
    Lalonde J
    Curr Opin Biotechnol; 2016 Dec; 42():152-158. PubMed ID: 27261887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mass spectrometry analysis of new chemical entities for pharmaceutical discovery.
    Fang AS; Miao X; Tidswell PW; Towle MH; Goetzinger WK; Kyranos JN
    Mass Spectrom Rev; 2008; 27(1):20-34. PubMed ID: 18033735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biocatalysis in drug discovery and development.
    Fryszkowska A; Devine PN
    Curr Opin Chem Biol; 2020 Apr; 55():151-160. PubMed ID: 32169795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the reactions used for the preparation of drug candidate molecules.
    Carey JS; Laffan D; Thomson C; Williams MT
    Org Biomol Chem; 2006 Jun; 4(12):2337-47. PubMed ID: 16763676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Boron reagents in process chemistry: Excellent tools for selective reductions.
    Burkhardt ER; Matos K
    Chem Rev; 2006 Jul; 106(7):2617-50. PubMed ID: 16836295
    [No Abstract]   [Full Text] [Related]  

  • 39. Asymmetric processes in the large-scale preparation of chiral drug candidates.
    O'Brien MK; Vanasse B
    Curr Opin Drug Discov Devel; 2000 Nov; 3(6):793-806. PubMed ID: 19649907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biocatalytic routes to chiral amines and amino acids.
    Gotor-Fernández V; Gotor V
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):784-97. PubMed ID: 19894190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.